For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 24-30, 2026
FDA and innovation FDA and CMS move on personalized gene therapies. The FDA released draft guidance that lets developers of…
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Search Posts
National Review
How Loosening Regulations Can Fight Coronavirus and Help the Economy
If a regulation isn’t needed during a crisis, it was probably never needed at all. To his credit, President Trump signed an executive order on May…
News Release
#NeverNeeded Regulation Report: Deploy Rational Science-Based Policies for Medical Plant Sterilization
After an EPA program produced a highly flawed assessment in 2016 that vastly overstated the risk of Ethylene Oxide (EtO), a critical gas used for…
Study
Deploy Rational Science-Based Policies for Medical Plant Sterilization
Several medical supply sterilization plants have shut down during the past year because of unwarranted fearmongering about ethylene oxide (EtO), a gas used to sterilize…
National Review
Let the Doctors Work
Buried in the recent announcement by the Bureau of Economic Analysis that real gross domestic product (GDP) decreased at an annual rate of 4.8 percent in the first…
Blog
A New Approach to COVID-19 Response
The new coronavirus—SARS-CoV-2, which causes the disease COVID-19—is here to stay until either a vaccine or herd immunity limits the number of people susceptible to…
News Release
#Neverneeded Regulation Report: CDC, FDA Response to COVID-19 Hindered by Mission Creep
The nation’s top federal agencies tasked with protecting public health have been increasingly distracted over recent years by dubious priorities having nothing to do with…